Featured Research

from universities, journals, and other organizations

Dizziness, Vertigo Treatment Options: National Guideline On Treatment For Common Cause Of Dizziness

Date:
November 1, 2008
Source:
American Academy of Otolaryngology -- Head and Neck Surgery
Summary:
The American Academy of Otolaryngology -- Head and Neck Surgery Foundation will issue a comprehensive clinical guideline to help healthcare practitioners identify and treat patients with benign paroxysmal positional vertigo, one of the most common underlying conditions that cause dizziness. The guideline emphasizes evidence-based recommendations on managing BPPV, the most common vestibular (inner ear) disorder in adults.

The American Academy of Otolaryngology – Head and Neck Surgery Foundation (AAO-HNSF) will issue a comprehensive clinical guideline to help healthcare practitioners identify and treat patients with benign paroxysmal positional vertigo (BPPV), one of the most common underlying conditions that cause dizziness. The guideline emphasizes evidence-based recommendations on managing BPPV, the most common vestibular (inner ear) disorder in adults.

Related Articles


BPPV is a disorder that causes feelings of vertigo, dizziness, and nausea. Episodes of BPPV can be brought on by abrupt changes in movement, like standing up or turning the head suddenly. The condition usually begins to affect people after the age of 50, but it can affect younger patients.

"Approximately 5.6 million medical appointments per year in the United States can be attributed to complaints of dizziness," said Neil Bhattacharyya, MD, chair of the multidisciplinary BPPV Guideline Panel. "We know now that anywhere from 17 to 42 percent of these patients will ultimately receive a diagnosis of BPPV. Unfortunately, proper diagnosis and treatment for those suffering is often delayed due to a lack of standardized diagnostic steps and relative unawareness of effective treatment options."

The primary purposes of the new AAO-HNSF guideline, for patients 18 years and older, are to improve quality of care and outcomes for BPPV by improving the accurate and efficient diagnosis of the condition, reducing the inappropriate use of suppressant medications, decreasing the inappropriate use of ancillary tests such as radiographic imaging and vestibular testing, and to promote the use of effective repositioning maneuvers for treatment.

Expenses relating to the diagnosis and treatment of BPPV cost the U.S. healthcare system approximately $2 billion per year. Additionally, 86 percent of patients suffer some interrupted daily activities and lost days at work because of BPPV.

Fortunately, BPPV can be readily diagnosed by clinicians in an outpatient setting most of the time without complicated testing. Once a proper diagnosis has been made, simple, effective treatment options are available to relieve symptoms quickly.

Some of the key recommendations of the guideline include:

  • A strong recommendation for clinicians to diagnose posterior semicircular canal BPPV with an office-based diagnostic test (the Dix-Hallpike maneuver, detailed within the guideline).
  • A recommendation for clinicians to also test patients for a second type of BPPV affecting the lateral semicircular canal when initial testing is not conclusive (using the supine roll test).
  • Clinicians should differentiate BPPV from other causes of imbalance, dizziness, and vertigo.
  • Clinicians should question patients with BPPV for factors that modify management including impaired mobility or balance, CNS disorders, a lack of home support, and increased risk for falling. These recommendations will help prevent some of the dangerous morbidities from BPPV.
  • Clinicians should not obtain radiographic imaging or vestibular testing in a patient diagnosed with BPPV, unless the diagnosis is uncertain or there are additional symptoms or signs unrelated to BPPV that warrant testing.
  • Clinicians should not routinely treat BPPV with vestibular suppressant medications such as antihistamines or benzodiazepines.
  • For patients who are initial treatment failures, clinicians should evaluate them for persistent BPPV or underlying peripheral vestibular or CNS disorders.
  • Clinicians should counsel patients regarding the impact of BPPV on their safety, the potential for disease recurrence, and the importance of follow-up.

The guideline was created by a multidisciplinary panel of clinicians representing the fields of otolaryngology, audiology, emergency medicine, physical medicine and rehabilitation, geriatrics, physical therapy, family physicians, neurology, and chiropractics.


Story Source:

The above story is based on materials provided by American Academy of Otolaryngology -- Head and Neck Surgery. Note: Materials may be edited for content and length.


Journal Reference:

  1. Bhattacharyya et al. Clinical practice guideline: Benign paroxysmal positional vertigo. Otolaryngology - Head and Neck Surgery, 2008; 139 (5): S47 DOI: 10.1016/j.otohns.2008.08.022

Cite This Page:

American Academy of Otolaryngology -- Head and Neck Surgery. "Dizziness, Vertigo Treatment Options: National Guideline On Treatment For Common Cause Of Dizziness." ScienceDaily. ScienceDaily, 1 November 2008. <www.sciencedaily.com/releases/2008/11/081101083923.htm>.
American Academy of Otolaryngology -- Head and Neck Surgery. (2008, November 1). Dizziness, Vertigo Treatment Options: National Guideline On Treatment For Common Cause Of Dizziness. ScienceDaily. Retrieved March 5, 2015 from www.sciencedaily.com/releases/2008/11/081101083923.htm
American Academy of Otolaryngology -- Head and Neck Surgery. "Dizziness, Vertigo Treatment Options: National Guideline On Treatment For Common Cause Of Dizziness." ScienceDaily. www.sciencedaily.com/releases/2008/11/081101083923.htm (accessed March 5, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, March 5, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com
Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Newsy (Mar. 5, 2015) A survey of Boston mothers and toddlers found that 15 percent of two-year-olds drink coffee and 2.5 percent of 1-year-olds. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins